文献速递消化、代谢与肾脏急症

验证预测静脉曲张性上消化道出血低风险患者的决策规则

Validation of a decision rule to predict patients at low risk of variceal upper gastrointestinal hemorrhage.
PubMed 文献 · Am J Emerg Med · 2020-04-07
一句话结论在21家加拿大医院2020例上消化道出血患者中验证仅用INR和血小板计数的决策规则,识别静脉曲张性出血低风险者敏感性95.3%,加既往静脉曲张出血史后97.7%。

该研究利用21家加拿大医院2020例上消化道出血患者数据,验证一个仅用INR和血小板计数的简易决策规则,以识别静脉曲张性出血低风险患者。原规则(INR≥1.3或血小板≤200×10^9/L任一存在即非低风险)敏感性95.3%(95%CI 91.6-97.7%),阴性似然比0.09(95%CI 0.05-0.16);加入既往静脉曲张出血史后敏感性升至97.7%(95%CI 94.6-99.2%),阴性似然比0.04(95%CI 0.02-0.11)。47%患者被归为低风险,其中仅0.5%发生静脉曲张性出血。作者认为该规则简单易用,可能有助于安全推迟不必要或有害的治疗。

要点

  • 原两步规则:INR≥1.3或血小板计数≤200×10^9/L任一存在即非低风险,验证队列敏感性95.3%(95%CI 91.6-97.7%),阴性似然比0.09(95%CI 0.05-0.16)。
  • 加入既往静脉曲张出血史作为第三步后,敏感性升至97.7%(95%CI 94.6-99.2%),阴性似然比0.04(95%CI 0.02-0.11)。
  • 2001例可分析患者中953例(47%)被归为低风险,其中5例(0.5%)发生静脉曲张性出血。
  • 作者认为该规则简单易用,可能有助于安全推迟不必要或有害的治疗。

适用人群与场景

  • 参与医院中年龄≥18岁、2004年1月至2005年5月期间因非静脉曲张性或静脉曲张性上消化道出血就诊的患者。

诊断标准与关键阈值

  • 原决策规则:INR≥1.3或血小板计数≤200×10^9/L任一存在即不判定为低风险。
  • 扩展规则:在上述两条基础上加入既往静脉曲张出血史,存在任一条件即不判定为低风险。

研究设计与关键结果

  • 多中心决策规则验证研究,数据来自21家加拿大医院,共2020例患者,2001例纳入分析,其中214例(10.7%)为静脉曲张性出血。
  • 中位年龄69岁(IQR 55-79),764例(38%)为女性。
  • 原两步规则正确识别214例静脉曲张性出血中的204例(95.3%);加入既往静脉曲张出血史后额外识别5例,共209/214例(97.7%)。
  • 2001例中953例(47%)被归为低风险,其中5例(0.5%)发生静脉曲张性出血。
  • 验证队列敏感性95.3%(95%CI 91.6-97.7%),阴性似然比0.09(95%CI 0.05-0.16);加入既往静脉曲张出血史后敏感性97.7%(95%CI 94.6-99.2%),阴性似然比0.04(95%CI 0.02-0.11)。

证据类型、等级与局限

  • 决策规则验证研究,使用多中心数据(21家加拿大医院)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为该规则简单易用,可能有助于安全推迟不必要或有害的治疗。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Determining the likelihood of a variceal versus nonvariceal source of upper gastrointestinal bleeding (UGIB) guides ED therapy, but can be difficult to determine on clinical grounds. A simple decision rule, using only platelet and international normalized ratio (INR) values, was previously derived in a single center and had high sensitivity (97%). We sought to validate this decision rule using multi-center data.

MATERIALS AND METHODS: We performed this decision rule validation using data collected from 21 Canadian hospitals, comprising 2020 patients. The parent study enrolled patients aged ≥18 years at participating hospitals with nonvariceal or variceal UGIB from January 2004 through May 2005. To validate the existing decision rule, we computed the test characteristics of the rule on this study population. The existing decision rule, in order to predict patients at low risk for variceal hemorrhage, is designed to be highly sensitive for variceal UGIB. In the previously derived rule, patients are not low risk if either is present: INR ≥1.3 or platelet count ≤200 × 109/L. We additionally added a third common-sense criterion to the decision rule in a separate analysis: whether the patient has previously had variceal hemorrhage.

RESULTS: 2001 patients were eligible for analysis, including 214 (10.7%) with a variceal source of gastrointestinal hemorrhage. Median age was 69 (IQR 55-79), and 764 (38%) were women. The two-step rule correctly identified 204 of the 214 (95.3%) patients with variceal hemorrhage; adding prior variceal hemorrhage as a variable identified 5 more patients (209/214 [97.7%]). Of the 2001 patients, 953 (47%) would have been classified as low risk for variceal hemorrhage; of these patients, 5 (0.5%) experienced variceal hemorrhage. The sensitivity of the rule in this validation cohort was 95.3% (95% CI 91.6-97.7%), with a negative likelihood ratio of 0.09 (95% CI 0.05-0.16). Adding prior variceal hemorrhage increased sensitivity to 97.7% (95% CI 94.6-99.2%), with a negative likelihood ratio of 0.04 (95% CI 0.02-0.11).

CONCLUSION: We have validated a simple decision rule to identify patients at low risk for variceal UGIB. This two-step (three-step if prior history of variceal hemorrhage is known) rule is simple to use, and may enable safe deferment of unnecessary or harmful therapies.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Driver BE, Horton G, Barkun A, et al. Validation of a decision rule to predict patients at low risk of variceal upper gastrointestinal hemorrhage. Am J Emerg Med. 2020. PMID: 32303409. doi:10.1016/j.ajem.2020.04.001

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。